Forex
World
Market
Business
Cryptocurrency
Commodities
MAP
Publish for free
Business
financetom
/
Business
/
--Shuttle Pharmaceuticals Soars Premarket Following Completion of Phase 2 Glioblastoma Trial Site Enrollment
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
Forex
Stocks Market
Commodities
--Shuttle Pharmaceuticals Soars Premarket Following Completion of Phase 2 Glioblastoma Trial Site Enrollment
Nov 3, 2024 1:27 PM
05:56 AM EDT, 10/29/2024 (MT Newswires) --
Price: 2.1806, Change: +0.85, Percent Change: +63.95
Previous page:
Nordson Closes Atrion Acquisition
Next page:
Monopar Receives Clearance in Australia for Phase 1 Trial of Radiopharmaceutical in Advanced Cancers
Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Release time ⇩
Release time ⇧
Like count ⇩
Show More Comments
Related Articles >
Nordson Closes Atrion Acquisition
Aug 21, 2024
09:01 AM EDT, 08/21/2024 (MT Newswires) -- Nordson ( NDSN ) said Wednesday it has closed the acquisition of medical device manufacturer Atrion ( ATRI ) . In May, Nordson ( NDSN ) said it agreed to buy Atrion ( ATRI ) for $460 per share in cash. Price: 241.00, Change: +1.53, Percent Change: +0.64 ...
Monopar Receives Clearance in Australia for Phase 1 Trial of Radiopharmaceutical in Advanced Cancers
Aug 21, 2024
08:50 AM EDT, 08/21/2024 (MT Newswires) -- Monopar Therapeutics ( MNPR ) said Wednesday it has received clearance from Australia's Human Research Ethics Committee to start a phase 1 therapeutic trial of its radiopharmaceutical MNPR-101-Lu. The MNPR-101-Lu trial will enroll patients with advanced solid cancers and will be a therapeutic follow-on study to its ongoing MNPR-101-Zr imaging and dosimetry trial,...
Atossa Therapeutics Doses First Patient in Breast Cancer Therapy Study
Aug 21, 2024
09:08 AM EDT, 08/21/2024 (MT Newswires) -- Atossa Therapeutics ( ATOS ) said Wednesday that it had dosed the first patient in a trial evaluating its experimental drug, (Z)-endoxifen, in combination with Eli Lilly's ( LLY ) abemaciclib as a neoadjuvant treatment for certain high-risk breast cancer patients. The study, which is part of the I-SPY network, will involve around...
Ford Stock Charges Higher On EV Strategy Shift: What Investors Need To Know
Aug 21, 2024
Ford Motor Co ( F ) shares are getting a boost Wednesday morning after the company announced plans to broaden its electrification strategy. What To Know: Ford announced that it’s taking additional actions to deliver a profitable, capital-efficient and growing electric vehicle business, including adjusting the company’s North America vehicle roadmap to offer a range of electrification options aimed at...
About
Terms and Conditions
Privacy policy
Cookie Settings
Contact Us
Services
Login
register
financetom
Market
Personal Finance
Business
Economy
Cryptocurrency
MAP
Links
zpostcode
Recruit
weather
mreligion
Yellowpages
sport
constellation
shopping
name
game
directory
literature
Word
tour
furnish
Lottery
tftnews
lyrics
News
digital
car
dir
Edu
Finance
Copyright 2023-2026 -
www.financetom.com
All Rights Reserved
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
MAP